Bio-Techne
TECH
#1481
Rank
C$16.50 B
Marketcap
$103.85
Share price
-0.37%
Change (1 day)
31.81%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2023 (TTM): $2.11

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is $2.19. In 2022 the company made an earnings per share (EPS) of $2.33 an increase over its 2021 EPS that were of $1.88.

EPS history for Bio-Techne from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.11-9.45%
2022$2.3324.35%
2021$1.8817.98%
2020$1.59-10.94%
2019$1.79101.57%
2018$0.89-17.53%
2017$1.0739.37%
2016$0.77-17.23%
2015$0.93-14.97%
2014$1.101.29%
2013$1.083.68%
2012$1.04-1.97%
2011$1.061.67%
2010$1.057.14%
2009$0.98-1.06%
2008$0.9919.41%
2007$0.8319.1%
2006$0.6910.56%
2005$0.6329.5%
2004$0.4913.05%
2003$0.4368.43%
2002$0.25-17.05%
2001$0.3117.33%
2000$0.2648.51%
1999$0.1823.17%
1998$0.1413.89%
1997$0.1342.57%
1996$0.08810

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$21.41 877.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$7.98-464.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.75 253.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$11.19 410.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.03-7.38%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$11.93 444.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.31-159.87%๐Ÿ‡บ๐Ÿ‡ธ USA